000 | 01691 a2200421 4500 | ||
---|---|---|---|
005 | 20250512000307.0 | ||
264 | 0 | _c19901011 | |
008 | 199010s 0 0 eng d | ||
022 | _a0360-3016 | ||
024 | 7 |
_a10.1016/0360-3016(90)90544-t _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSantos, O | |
245 | 0 | 0 |
_aRadiation, pool size and incorporation studies in mice with 5-chloro-2'-deoxycytidine. _h[electronic resource] |
260 |
_bInternational journal of radiation oncology, biology, physics _cAug 1990 |
||
300 |
_a357-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAspartic Acid _xanalogs & derivatives |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCytidine Deaminase _xantagonists & inhibitors |
650 | 0 | 4 |
_aDNA, Neoplasm _xmetabolism |
650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C3H |
650 | 0 | 4 |
_aPhosphonoacetic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xpharmacokinetics |
650 | 0 | 4 |
_aSarcoma, Experimental _xdrug therapy |
650 | 0 | 4 |
_aTetrahydrouridine _xtherapeutic use |
650 | 0 | 4 |
_aUracil _xanalogs & derivatives |
650 | 0 | 4 |
_aUridine Phosphorylase _xantagonists & inhibitors |
700 | 1 | _aPerez, L M | |
700 | 1 | _aBriggle, T V | |
700 | 1 | _aBoothman, D A | |
700 | 1 | _aGreer, S B | |
773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 19 _gno. 2 _gp. 357-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0360-3016(90)90544-t _zAvailable from publisher's website |
999 |
_c2400681 _d2400681 |